Herpes Virus is a Cause of Alzheimer’s Disease; CBCD Reviews the Medical Evidence

“Infected with the herpes virus (HSV-1 or HSV-2)? The CBCD recommends taking Novirin or Gene-Eden-VIR.” – Greg Bennett, CBCD

According to two new Swedish studies, individuals infected with the herpes virus are twice as likely to develop Alzheimer’s disease (AD). “The first study involved nearly 3,500 people who were followed for an average of 11 years; the researchers found that those who had certain antibodies to a herpes infection doubled their risk for developing Alzheimer’s disease.” (1) Dr. Hugo Lovheim, the lead researcher in the study, said that “I think (the) herpes virus causes a significant proportion of all cases of AD – about 40 to 50 percent – according to our data.” (1) According to the researchers, “the identification of a treatable cause (herpes simplex) of the most common dementia disorder is a breakthrough … whether treatment of herpes infection with antiviral drugs may slow the Alzheimer’s progression is not known, but is certainly worth investigating in clinical studies.” (1) The Center for the Biology of Chronic Disease (CBCD) points out that there are two post-marketing clinical studies, which found that the formula of Novirin and Gene-Eden-VIR safely reduced herpes symptoms.

Click to learn more about herpes symptoms.

The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the Center for the Biology of Chronic Disease (CBCD) in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HSV-1, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (HSV-1 and other viruses)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

“Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive decline in cognitive functions leading to memory loss and dementia.” (3)

How does the herpes virus cause AD?

The oral herpes virus infects a type of cell called an epithelial cell, which is found in the mouth. Once a person is infected the virus replicates, and uses nerves to travel to the brain. Once in the brain, the virus establishes a latent infection. From time to time, the virus travels back to the original site of infection, replicates and causes the well-known clinical lesions (i.e., cold sores and blisters). (3)

In the brain, “it may cause acute neurological disorders like encephalitis [herpes simplex encephalitis (HSE)] or a mild, clinically asymptomatic, infection, or establish life-long latent infection.” (3) The weakening of the immune system, which occurs during aging, only serves to increase the damage the virus causes.

In addition, “several studies have been performed to assess the presence of HSV-1 in the brain of AD patients…other studies have demonstrated that HSE affected the same brain areas involved in AD in humans as well as in rodent experimental models … (and other studies)… reported that a high proportion (about 60%) of brains of elderly people contained latent HSV-1 DNA, especially in the CNS regions critically involved in AD.” (3) In other words, the virus is repeatedly found in the brains of those who develop Alzheimer’s disease, and in regions typically affected by the disease.

What treatments are available against the herpes virus?

“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (2)

In light of this evidence, the CBCD recommends targeting the latent herpes virus with Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was designed to help the immune system target the latent HSV-1.

Click to learn more about Novirin and HSV and Gene-Eden-VIR and HSV.

References:

(1) Pedersen, T. Herpes Simplex Virus May Up Risk of Alzheimer’s. PsychCentral.com. Published on November 20, 2014.

https://psychcentral.com/news/2014/11/20/herpes-simplex-virus-may-up-risk-of-alzheimers/77541.html

(2) Polansky, H., Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013. cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(3) HSV-1 and Alzheimer’s disease: more than a hypothesis. Published on May 7, 2014. ncbi.nlm.nih.gov/pubmed/24847267

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (https://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.